干扰素-γ释放试验作为系统性红斑狼疮新型生物标志物的研究
在99例SLE患者中,标准化IGRA-NL与疾病活动的相关性优于抗dsDNA或补体水平。
要点
- SIR升高(>中位数5个标准差)与SLE、结核感染、噬血细胞性淋巴组织细胞增多症及HIV感染相关。
- SLE患者中标准化IGRA-NL与疾病活动的相关性优于抗dsDNA或补体水平。
- 该关联可能反映标准化IGRA-NL与急性皮肤病变、低补体血症、发热及血小板减少的相互作用。
核心结论
- SIR升高似乎与包括SLE在内的有限疾病过程相关。
- SIR的诊断效用尚待确定。
- 通过TB-IGRA测量的IFN-γ激活可能为评估SLE患者疾病活动提供 readily available 工具。
研究设计与样本
- 识别99例有TB-IGRA检测结果的SLE患者,评估IGRA-NL、标准化IGRA-NL与疾病表现及疾病活动之间的相关性。
主要发现
- 发现108例SIR升高(>中位数5个标准差)的发现队列,该队列显著富集于包括SLE、结核感染、噬血细胞性淋巴组织细胞增多症和HIV感染在内的有限诊断。
- 在SLE患者中,标准化IGRA-NL与疾病活动的相关性优于抗dsDNA或补体水平。
- 该关系似乎反映标准化IGRA-NL与急性皮肤病变、低补体血症、发热和血小板减少的存在之间的相互作用。
临床怎么用
- TB-IGRA检测中的IGRA-NL可能作为评估SLE疾病活动的可用工具。
- SIR升高时应考虑SLE等有限疾病过程的诊断关联。
局限性
- SIR的诊断效用尚待确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The mycobacterium tuberculosis (TB) IFN-γ release assay (TB-IGRA) assesses peripheral blood cell release of IFN-γ upon ex vivo exposure to mitogen (IGRA-MT), TB antigen or a negative/nil control (IGRA-NL); IGRA-NL is a measure of spontaneous IFN-γ release (SIR). Here, we investigate the diagnostic associations of elevated SIR and the potential use of IGRA-NL as a novel biomarker in SLE. METHODS: We analysed diagnostic code frequencies among 11 823 individuals undergoing TB-IGRA testing between 2010 and 2015 in a large urban US health-care system. To study the relationship between IGRA-NL and SLE, we identified 99 individuals with SLE and TB-IGRA test results then assessed correlations between IGRA-NL, normalized IGRA-NL (the quotient of IGRA-NL/IGRA-MT), disease manifestations and disease activity. RESULTS: We identified a discovery cohort of 108 individuals with elevated SIR (>5 S.d. above median) that was significantly enriched for a limited set of diagnoses, including SLE, TB infection, haemophagocytic lymphohistiocytosis and HIV infection. In SLE patients undergoing TB-IGRA testing, normalized IGRA-NL correlated better with disease activity than did anti-dsDNA or complement levels. This relationship appeared to reflect interactions between normalized IGRA-NL and the presence of acute skin disease, hypocomplementemia, fever and thrombocytopenia. CONCLUSION: Elevated SIR appears to be associated with a limited number of disease processes, including SLE. The diagnostic utility of SIR remains to be determined. IFN-γ activation, as measured by the TB-IGRA test, may offer a readily available tool for assessing disease activity in patients with SLE.
引用
- Thomason JL, Obih UM, Koelle DM, et al. An interferon-gamma release assay as a novel biomarker in systemic lupus erythematosus. Rheumatology (Oxford). 2020. PMID: 32375180. doi:10.1093/rheumatology/keaa161
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。